NYSE: PEN

Price 71.55
-0.22 -0.31%
08/29/16
Volume: 160,590
Pricing delayed 20 minutes More >

Investor Overview

Headquartered in Alameda, California, Penumbra, Inc. is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

SEC Filings

Date Filing Type Filing Description Download / View
08/29/2016 4 Statement of Changes in Beneficial Ownership
08/29/2016 4 Statement of Changes in Beneficial Ownership
08/29/2016 4 Statement of Changes in Beneficial Ownership

Email Alerts

Mailing Lists *


Email Address *

 
Enter the code shown above.

Investor Contact